Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Melanoma × Vancomycin × Clear all

Phase

Phase 1/2 1 Phase 1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Early Stage Non-Small Cell Lung Cancer 1

Interventions

pembrolizumab 78 Nivolumab 48 Ipilimumab 47 Cyclophosphamide 44 Vemurafenib 22 Interleukin-2 22 fludarabine 21 aldesleukin 20 trametinib 19 fludarabine phosphate 16 dabrafenib 14 Biopsy 13 Temozolomide 12 Cisplatin 12 atezolizumab 10 Introns 10 spartalizumab 9 poly ICLC 9 Specimen Handling 9 Radiosurgery 9 Carboplatin 9 incomplete Freund's adjuvant 8 cobimetinib 8 Radiation 8 Paclitaxel 8 Magnetic Resonance Spectroscopy 8 MART-1 Antigen 8 Filgrastim 8 Docetaxel 8 tremelimumab 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06540391 2025-09-26

MELODY-1

Microbiotica Ltd

Phase 1 Active not recruiting

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡